Change in HAQ* univariate associations | Change in HAQ* multivariable | |||
---|---|---|---|---|
B (95% CI) | p Value | B (95% CI) | p Value | |
Δ Synovitis (per 1 unit) | 0.046 (0.022 to 0.069) | <0.001 | 0.053 (0.029 to 0.077) | <0.001 |
MRI erosion progression | 0.35 (0.13 to 0.57) | 0.002 | 0.36 (0.12 to 0.59) | 0.003 |
X-ray progression | 0.081 (−0.13 to 0.29) | 0.45 | −0.063 (−0.28 to 0.15) | 0.56 |
Change pain (VAS)* univariate | Change in pain (VAS)* multivariable | |||
B (95% CI) | p Value | B (95% CI) | p Value | |
Δ Synovitis (per 1 unit) | 0.15 (0.054 to 0.25) | 0.002 | 0.16 (0.058 to 0.25) | 0.002 |
MRI erosion progression | 1.47 (0.57 to 2.36) | 0.001 | 1.42 (0.47 to 2.37) | 0.004 |
X-ray progression | 0.59 (−0.25 to 1.43) | 0.17 | −0.067 (−0.93 to 0.80) | 0.88 |
Change patient global (VAS)* univariate | Change in patient global (VAS)* multivariable | |||
B (95% CI) | p Value | B (95% CI) | p Value | |
Δ Synovitis (per 1 unit) | 0.16 (0.066 to 0.25) | 0.001 | 0.16 (0.066 to 0.25) | 0.001 |
MRI erosion progression | 1.47 (0.61 to 2.33) | 0.001 | 1.35 (0.44 to 2.25) | 0.004 |
X-ray progression | 0.66 (−0.15 to 1.46) | 0.11 | 0.029 (−0.79 to 0.85) | 0.95 |
Osteitis was not associated independently (not shown). Treatment interactions with MRI measures were tested and non-significant.
Adjusted for baseline value.
HAQ, Health Assessment Questionnaire; VAS, visual analogue scale.